Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Protez Pharmaceuticals logo — Pioneering advanced antibiotics to combat hospital-based inf...

Protez Pharmaceuticals

Pioneering advanced antibiotics to combat hospital-based infections and bacterial resistance since 2003.

Founded 2003 9 employees Series B Total: $15.00M Health Care, Pharmaceutical

General Information

Company Name Protez Pharmaceuticals
Founded Year 2003
Employees 9
Industries Health Care, Pharmaceutical
Funding Stage Series B
Social

BounceWatch is an independent company data service, not affiliated with Protez Pharmaceuticals. To contact Protez Pharmaceuticals, visit protez.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Protez Pharmaceuticals compare?

A PDF of Protez Pharmaceuticals and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Protez Pharmaceuticals soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Protez Pharmaceuticals

Protez Pharmaceuticals is a pioneering medical research company committed to combating challenging hospital-based infections and bacterial resistance. Founded in 2003 by Christopher M. Cashman, the organization focuses on the discovery, development, and commercialization of advanced antibiotics. It specializes in producing both intravenous and oral small molecule antibiotics designed to combat bacterial resistance and manage chronic or recurring infections. Based in Malvern, Pennsylvania, the company received a notable $15.00M Series B investment on 01 August 2005 from a consortium of prominent investors including BioAdvance, Birchmere Ventures, Bay City Capital, SR One, and L Capital Partners. Protez Pharmaceuticals' steadfast dedication to combatting antibiotic resistance and hospital-based infections positions it as a promising candidate for investment within the Health Care and Pharmaceutical industries.

Business keywords: medical research, antibiotics, hospital-based infections, bacterial resistance, small molecule antibiotics, intravenous antibiotics, oral antibiotics, chronic infections, recurring infections, Christopher M. Cashman, Malvern, Pennsylvania, pharmaceuticals, drug discovery, drug development, commercialization

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Series B $15.00M 5
BioAdvance Birchmere Ventures Bay City Capital
BioAdvance, Birchmere Ventures +3
01 Aug 2005
Venture Round Undisclosed 1
BioAdvance
BioAdvance
01 Jun 2004
Series A Undisclosed 1
BTG International
BTG International
24 Feb 2004

Protez Pharmaceuticals Alternatives & Competitors

View All Alternatives
Protez Pharmaceuticals vs
Synereca Pharmaceuticals
Synereca Pharmaceuticals

Pioneering orally active drugs to rejuvenate antibiotic efficacy against lung, urinary tract, and sk...

Venture round
Biotechnology, Health Care
Protez Pharmaceuticals vs
Biocidium Biopharmaceuticals
Biocidium Biopharmaceuticals Canada

Clinical-stage biopharmaceutical company focused on novel antibiotics, antifungals, and treatments f...

1 employees
Biopharma, Biotechnology
Protez Pharmaceuticals vs
SelectX Pharmaceuticals
SelectX Pharmaceuticals United States

SelectX Pharmaceuticals is a biopharmaceutical company that focuses on the discovery and development...

Series B
6 employees
Biotechnology, Health Care
View all alternatives

FAQ About Protez Pharmaceuticals

Pioneering advanced antibiotics to combat hospital-based infections and bacterial resistance since 2003.
Protez Pharmaceuticals was founded in 2003.
Protez Pharmaceuticals operates in Health Care and Pharmaceutical. Its work centres on medical research, antibiotics, hospital-based infections and bacterial resistance.
Protez Pharmaceuticals has approximately 9 employees.
Protez Pharmaceuticals has completed 3 funding rounds, raising a total of $15.00M. The latest funding stage is Series B.
Top alternatives and competitors to Protez Pharmaceuticals include Synereca Pharmaceuticals, Biocidium Biopharmaceuticals, SelectX Pharmaceuticals, Altay Therapeutics, Adaptive Phage Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Protez Pharmaceuticals and Synereca Pharmaceuticals are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Protez Pharmaceuticals, https://bouncewatch.com/company/protez-pharmaceuticals, updated 4 January 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout